Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiated thyroid cancer: "complete" rational approach.

E Kebebew1, O H Clark

  • 1Department of Surgery, School of Medicine, University of California, San Francisco, 513 Parnassus Street, San Francisco, California 94143-0470, USA.

World Journal of Surgery
|June 24, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.

Oncogene·2017
Same author

Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.

The Journal of clinical endocrinology and metabolism·2015
Same author

Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.

The Journal of clinical endocrinology and metabolism·2014
Same author

Functional thermogenic beige adipogenesis is inducible in human neck fat.

International journal of obesity (2005)·2013
Same author

KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.

Endocrine-related cancer·2012
Same author

The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.

Endocrine-related cancer·2012
Same journal

Prediction Models for Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer: Validation of Existing Nomograms, Model Development, and Ensemble Evaluation.

World journal of surgery·2026
Same journal

Indicators for Monitoring Recovery From Surgery to Discharge Using Accelerometer in Patients With Esophageal Cancer.

World journal of surgery·2026
Same journal

The Safety of In-Hospital Delay and the Utility of dNLR in Elderly Patients With Acute Appendicitis.

World journal of surgery·2026
Same journal

Feasibility of Post-Operative Telehealth for Pediatric Surgical Patients in Malawi-A Mixed Methods Analysis.

World journal of surgery·2026
Same journal

Surgical Infrastructure and Workforce Readiness in Rwanda's District and Level 2 Teaching Hospitals: A Nationwide Facility-Based Survey.

World journal of surgery·2026
Same journal

From General Preparedness to Injury-Pattern-Specific Trauma Resource Planning.

World journal of surgery·2026
See all related articles

Optimal management for differentiated thyroid cancer is debated due to limited studies. However, extensive thyroidectomy with radioactive iodine and TSH suppression therapy offers better survival and lower recurrence rates for most patients.

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Oncology

Background:

  • Optimal management for differentiated thyroid cancer lacks prospective randomized trials.
  • Low-risk differentiated thyroid cancer has a good prognosis but recurrence rates can be significant.
  • Current treatment strategies include extent of thyroidectomy, radioactive iodine ablation, and TSH suppressive therapy.

Purpose of the Study:

  • To review the current evidence and controversies in the management of differentiated thyroid cancer.
  • To evaluate the benefits of different treatment modalities including extent of thyroidectomy, radioactive iodine ablation, and TSH suppressive therapy.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of prognostic factors and treatment outcomes in differentiated thyroid cancer.

Related Experiment Videos

  • Discussion of the advantages of total or near-total thyroidectomy versus lobectomy.

    • Main Results:

    • Total or near-total thyroidectomy offers advantages in detecting/treating residual disease and monitoring recurrence via thyroglobulin levels.
    • Radioactive iodine ablation and TSH suppressive therapy, combined with extensive surgery, are associated with improved survival and reduced recurrence rates.
    • Thyroid lobectomy may be suitable for specific low-risk cases like occult papillary or minimally invasive follicular thyroid cancer.

    Conclusions:

    • Most patients with differentiated thyroid cancer benefit from more extensive initial treatment, including total or near-total thyroidectomy.
    • While lobectomy is appropriate for select low-risk cases, comprehensive treatment including radioactive iodine and TSH suppression is recommended for broader patient groups.
    • Further prospective studies are needed to definitively establish optimal management protocols for all differentiated thyroid cancer patient subgroups.